Patents Assigned to BioCis Pharma Oy
  • Pharmaceutical composition for intracellular acidification with cis-urocanic acid
    Patent number: 8673281
    Abstract: A pharmaceutically acceptable agent able to acidify the cell cytoplasm, for the manufacture of a pharmaceutical composition useful for causing immunosuppression in a person or animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal, and where the agent is admixed with a carrier to adjust the pH of the composition to the pH range 6.1 to 7.0. A pharmaceutical composition is also disclosed.
    Type: Grant
    Filed: August 14, 2012
    Date of Patent: March 18, 2014
    Assignee: BioCis Pharma Oy
    Inventors: Lasse Leino, Jarmo Laihia
  • Pharmaceutical composition for intracellar acidification with cis-urocanic acid
    Patent number: 8673280
    Abstract: A pharmaceutically acceptable agent able to acidify the cell cytoplasm for the manufacture of a pharmaceutical composition useful for causing immunosuppression in a person or animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal, and where the agent is admixed with a carrier to adjust the pH of the composition to the pH range 6.1 to 7.0. A pharmaceutical composition is also disclosed.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: March 18, 2014
    Assignee: BioCis Pharma Oy
    Inventors: Lasse Leino, Jarmo Laihia
  • PHARMACEUTICAL COMPOSITION FOR INTRACELLAR ACIDIFICATION WITH CIS-UROCANIC ACID
    Publication number: 20130041006
    Abstract: A pharmaceutically acceptable agent able to acidify the cell cytoplasm for the manufacture of a pharmaceutical composition useful for causing immunosuppression in a person or animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal, and where the agent is admixed with a carrier to adjust the pH of the composition to the pH range 6.1 to 7.0. A pharmaceutical composition is also disclosed.
    Type: Application
    Filed: October 15, 2012
    Publication date: February 14, 2013
    Applicant: BIOCIS PHARMA OY
    Inventor: BioCis Pharma Oy
  • Anti-proliferative pharmaceutical composition
    Patent number: 8338475
    Abstract: The use of urocanic acid or another pharmaceutically acceptable agent being able to acidify the cell cytoplasm for the manufacture of a pharmaceutical composition useful for causing inhibition or halting of transformed or non-transformed cell proliferation in a person or an animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal. The use of the agent as an enhancer for other therapeutically active agents, and a pharmaceutical composition, are also disclosed.
    Type: Grant
    Filed: April 21, 2006
    Date of Patent: December 25, 2012
    Assignee: BioCis Pharma Oy
    Inventors: Lasse Leino, Jarmo Laihia
  • Pharmaceutical composition for intracellular acidification with cis-urocanic acid
    Patent number: 8313738
    Abstract: A pharmaceutically acceptable agent able to acidify the cell cytoplasm, for the manufacture of a pharmaceutical composition useful for causing immunosuppression in a person or animal, where an effective amount of the agent is administered in an essentially non-dissociated form to the person or animal, and where the agent is admixed with a carrier to adjust the pH of the composition to the pH range 6.1 to 7.0. A pharmaceutical composition is also disclosed.
    Type: Grant
    Filed: March 1, 2004
    Date of Patent: November 20, 2012
    Assignee: BioCis Pharma Oy
    Inventors: Lasse Leino, Jarmo Laihia